DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation

被引:75
作者
Burrows, JF
McGrattan, MJ
Rascle, A
Humbert, M
Baek, KH
Johnston, JA
机构
[1] Queens Univ Belfast, Dept Microbiol & Immunol, Belfast BT9 7BL, Antrim, North Ireland
[2] DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA
[3] Pochon CHA Univ, Coll Med, Cell & Gene Therapy Res Inst, Seoul, South Korea
关键词
D O I
10.1074/jbc.M311291200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies have identified the DUB family of cytokine-regulated murine deubiquitinating enzymes, which play a role in the control of cell proliferation and survival. Through data base analyses and cloning, we have identified a human cDNA (DUB-3) that shows significant homology to the known murine DUB family members. Northern blotting has shown expression of this gene in a number of tissues including brain, liver, and muscle, with two transcripts being apparent (1.6 and 1.7 kb). In addition, expression was observed in cell lines including those derived from a number of hematopoietic tumors such as the Burkitt's lymphoma cell line RAJI. We have also demonstrated that DUB-3, which was shown to be an active deubiquitinating enzyme, is induced in response to interleukin-4 and interleukin-6 stimulation. Finally, we have demonstrated that constitutive expression of DUB-3 blocks proliferation and can initiate apoptosis in both IL-3-dependent Ba/F3 cells and NIH3T3 fibroblasts. These findings suggest that human DUB-3, like the murine DUB family members, is transiently induced in response to cytokines and can, when constitutively expressed, block growth factor-dependent proliferation.
引用
收藏
页码:13993 / 14000
页数:8
相关论文
共 54 条
[1]  
Baek KH, 2003, EXP MOL MED, V35, P1
[2]   DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes [J].
Baek, KH ;
Mondoux, MA ;
Jaster, R ;
Fire-Levin, E ;
D'Andrea, AD .
BLOOD, 2001, 98 (03) :636-642
[3]   Association of UNP, a ubiquitin-specific protease, with the pocket proteins pRb, p107 and p130 [J].
Blanchette, P ;
Gilchrist, CA ;
Baker, RT ;
Gray, DA .
ONCOGENE, 2001, 20 (39) :5533-5537
[4]   Deregulated degradation of the cdk inhibitor p27 and malignant transformation [J].
Bloom, J ;
Pagano, M .
SEMINARS IN CANCER BIOLOGY, 2003, 13 (01) :41-47
[5]   Stat proteins and oncogenesis [J].
Bromberg, J .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (09) :1139-1142
[6]   A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division [J].
Cai, SY ;
Babbitt, RW ;
Marchesi, VT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :2828-2833
[7]   Deubiquitinating enzymes: A new class of biological regulators [J].
D'Andrea, A ;
Pellman, D .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 33 (05) :337-352
[8]   The de-ubiquitinating enzyme Unp interacts with the retinoblastoma protein [J].
DeSalle, LM ;
Latres, E ;
Lin, D ;
Graner, E ;
Montagnoli, A ;
Baker, RT ;
Pagano, M ;
Loda, M .
ONCOGENE, 2001, 20 (39) :5538-5542
[9]   Regulation of the G1 to S transition by the ubiquitin pathway [J].
DeSalle, LM ;
Pagano, M .
FEBS LETTERS, 2001, 490 (03) :179-189
[10]   The two faces of IL-6 on Th1/Th2 differentiation [J].
Diehl, S ;
Rincón, M .
MOLECULAR IMMUNOLOGY, 2002, 39 (09) :531-536